Media resources

Choosing the right COA instrument should be one of the earliest decisions in clinical development. And it is one that can have long-term consequences for your trial. Should you use an existing instrument? Develop a new...

On World Heart Day, ICON is proud to highlight the importance of preventing, diagnosing and treating heart disease. Over the past five years, ICON has participated in more than 300 studies across heart failure, ischaemic...

Clinical development rarely follows a straight line. That's why ICON's Manufacturing & Pharmacy Services are designed to provide real-time dose flexibility, rapid manufacturing support, and integrated regulatory expertis...

Modern RBQM models redistribute monitoring activities across central, remote and onsite teams, helping sponsors focus oversight where it matters most. In her article for BioPharm International, Helen Yeardley examines w...

Improved research accuracy and integrity. Knowledge Manager centralized content management avoids content duplication and ensures article accuracy and data integrity. See how it could help your work. Get more information...

ICON is a proud sponsor of this year’s World Patient Safety Congress. From early development through post-marketing, ICON works with organisations of all sizes to advance patient safety, optimise safety operations and s...

Rare disease clinical trials frequently depend on biomarker and genetic testing to identify appropriate patients for enrolment, yet suitable assays are not always commercially available or fit for purpose. During this pr...

The pressure to make confident development decisions earlier has never been greater. Discover how innovative early phase trial designs, patient engagement strategies, and biomarker insights are helping sponsors navigate ...

During World Alzheimer's Month, we're recognising the importance of advancing research for people affected by Alzheimer's disease. See how ICON partnered with a sponsor to overcome complex operational challenges, achievi...

Our people are central to ICON’s success. Across our global workforce, we continued investing in career development, learning opportunities and workplace culture during 2025. Employee feedback highlighted flexible worki...

As RBQM adoption grows, sponsors are rethinking how monitoring resources, data and expertise are deployed across studies. In this article for BioPharm International, Helen Yeardley explores why effective capacity planni...

Support, development and flexibility can make a real difference throughout a CRA career. For Eunyong, CRA II in Germany, joining ICON has given her the opportunity to build confidence through structured onboarding, in f...